LearnSkin
Course: Biosimilars: Where Are We Now?
Biosimilars: Where Are We Now?
Paul Yamauchi, MD PhD

Biosimilar medications are "highly similar" to an already FDA-approved biological product. Several biosimilars have already been approved in the US for the treatment of psoriasis, with more sure to follow in the near future. The FDA is responsible for and has a process for ensuring the safety and efficacy of biosimilars.

Faculty

User: paulyamauchi@yahoo.com
Paul Yamauchi
MD PhD

Dr. Yamauchi is a dermatologist in private practice and medical director at both the Dermatology Insitute and Skin Care Center and Clinical Science Institute in Santa Monica, California. HHe has admitting privileges and is on staff at St. John’s Hospital in Santa Monica and the UCLA MedicalCenter. Dr. Yamauchi is a clinical assistant professor of medicine in the Division of Dermatology at the David Geffen School of Medicine at UCLA and Harbor-UCLA Medical Center and Associate Professor at the John Wayne Cancer Institute in Santa Monica, CA. He specializes in medical and complex dermatology, dermatologic surgery, aesthetic dermatology, and clinical research.

Dr. Yamauchi earned his BS in biochemistry at the University of California at Los Angeles, his PhD in biologic chemistry at the University of California at Santa Barbara, and his MD at Case Western Reserve University School of Medicine in Cleveland. He completed his residency in dermatology at UCLA School of Medicine and a cosmetic surgery fellowship affiliated with UCLA School of Medicine.

View Bio

Editors

User: jasonhawkes@learnskin.com
Jason Hawkes
MD, MS, FAAD

Dr. Hawkes is a board-certified dermatologist and Investigator at the Oregon Medical Research Center in Portland, Oregon. He completed his medical school and residency at the University of Utah. During medical school, he completed a fellowship in translational immunology in the NIH-HHMI Research Scholars Program. He also received a Master’s Degree in Clinical Investigation from Rockefeller University, where he was Chief Clinical Scholar and Principal and sub-Investigator on multiple human research protocols in the Laboratory for Investigative Dermatology. He has held academic appointments in the Departments of Dermatology at the University of Utah, University of California-Davis, Icahn School of Medicine at Mount Sinai.

Dr. Hawkes is a current Councilor in the International Psoriasis Council and serves on the NPF Medical Board and Scientific Advisory Committee. He also serves as the official delegate of the AAD as a member of the international guidelines and workgroup committee for urticaria. His research has been funded by the NIH, NSF, NPF, and Dermatology Foundation, and he is the recipient of several teaching awards including NPF Outstanding Educator in Psoriatic Disease and Exceptional Teacher of the Year in the Department of Dermatology at Mount Sinai. His primary clinical and research interests include novel immune therapies for inflammatory conditions like psoriasis, atopic dermatitis, HS, alopecia areata, vitiligo, and urticaria.

View Bio

Related Courses

LearnSkin Logo
All material on this website is protected by copyright. Copyright © LearnHealth Inc. 2024.
This website also contains material copyrighted by 3rd parties.
ABOUT
LEGAL
SUBSCRIBE
To Get Posts Directly In Your Inbox!